Structures by: Kaur M.
Total: 167
<i>N</i>-(4-Bromo-3-methylphenyl)-2-(2-chlorophenyl)acetamide
C15H13BrClNO
Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 889-894
a=11.8458(8)Å b=4.7282(3)Å c=25.0757(15)Å
α=90° β=98.133(5)° γ=90°
Flunarizinium nicotinate
C26H27F2N2,C6H4NO2
Acta Crystallographica Section C (2014) 70, 8
a=10.8536(4)Å b=10.8103(4)Å c=11.3901(4)Å
α=90° β=92.717(2)° γ=90°
Flunarizinediium bis(4-toluenesulfonate) dihydrate
C26H28F2N22,2(C7H7O3S),2H2O
Acta Crystallographica Section C (2014) 70, 8
a=10.0546(5)Å b=14.8338(6)Å c=26.9437(12)Å
α=90° β=106.497(3)° γ=90°
<i>N</i>-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazol-4-yl)-2-(4-nitrophenyl)acetamide
C19H18N4O4
Acta Crystallographica Section E (2014) 70, 6 o636-o637
a=6.7023(6)Å b=8.6335(8)Å c=15.8720(13)Å
α=76.305(7)° β=84.399(7)° γ=77.252(7)°
Flunarizinium isonicotinate
C26H27F2N2,C6H4NO2
Acta Crystallographica Section E (2014) 70, 6 o681-o682
a=11.0023(3)Å b=10.6435(3)Å c=11.3393(3)Å
α=90° β=92.481(3)° γ=90°
Pyrimethaminium 2-{[4-(trifluoromethyl)phenyl]sulfanyl}benzoate dimethyl sulfoxide monosolvate
C12H14ClN4,C14H8F3O2S,C2H6OS
Acta Crystallographica Section E (2014) 70, 6 o683-o684
a=12.7422(3)Å b=22.2773(3)Å c=11.1761(3)Å
α=90° β=114.014(3)° γ=90°
4-pyrimidin-2-yl-piperazin-1-ium fumarate
C8H13N4,C4H3O4
Acta Crystallographica Section E (2014) 70, 6 o702-o703
a=12.3425(5)Å b=7.0365(3)Å c=14.7178(6)Å
α=90° β=94.213(3)° γ=90°
1(2-Furoyl)piperazinium 3,5-dinitrobenzoate
C9H13N2O2,C7H3N2O6
Acta Crystallographica Section E (2014) 70, 6 o700-o701
a=9.6060(2)Å b=10.4572(2)Å c=33.8766(7)Å
α=90° β=90° γ=90°
3-Amino-1<i>H</i>-pyrazol-2-ium trifluoroacetate
C3H6N3,C2F3O2
Acta Crystallographica Section E (2013) 69, 9 o1425-o1426
a=10.9292(8)Å b=10.9332(6)Å c=13.7002(13)Å
α=90° β=107.939(9)° γ=90°
4-Hydroxy-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-6(5<i>H</i>)-one dihydrate
C15H12N4O4,2(H2O)
Acta Crystallographica Section E (2013) 69, 11 o1707-o1708
a=9.5817(3)Å b=13.9439(3)Å c=12.4804(4)Å
α=90° β=109.832(3)° γ=90°
Bis-[1-(benzo[1,3]dioxol-5-yl-methyl)piperazinyl]methane
C25H32N4O4
Acta Crystallographica Section E (2013) 69, 11 o1669
a=38.8025(10)Å b=9.7675(2)Å c=6.09571(13)Å
α=90° β=90° γ=90°
<i>N</i>-(1,3-Benzothiazol-2-yl)acetamide
C9H8N2OS
Acta Crystallographica Section E (2013) 69, 11 o1622
a=11.1852(4)Å b=7.4037(4)Å c=20.9189(8)Å
α=90° β=94.408(3)° γ=90°
2-[4-(Trifluoromethyl)phenylsulfanyl]benzoic acid
C14H9F3O2S
Acta Crystallographica Section E (2013) 69, 11 o1704
a=7.3071(5)Å b=8.0790(7)Å c=11.3878(11)Å
α=82.678(8)° β=83.642(7)° γ=72.309(7)°
<i>N</i>-(1<i>H</i>-Indol-3-ylmethylidene)-4-methylpiperazin-1-amine
C14H18N4
Acta Crystallographica Section E (2013) 69, 11 o1706
a=7.5630(5)Å b=6.5593(4)Å c=13.2319(9)Å
α=90° β=100.072(6)° γ=90°
1-[4-(4-Hydroxyphenyl)piperazin-1-yl]ethanone
C12H16N2O2
Acta Crystallographica Section E (2013) 69, 11 o1671
a=6.13183(19)Å b=12.0106(4)Å c=14.8704(5)Å
α=90° β=94.025(3)° γ=90°
3,4-Dimethylphenyl quinoline-2-carboxylate
C18H15NO2
Acta Crystallographica Section E (2013) 69, 12 o1853-o1854
a=6.19172(17)Å b=15.4196(4)Å c=14.6585(4)Å
α=90° β=90.761(3)° γ=90°
Raltegravir monohydrate
C20H21FN6O5,H2O
Acta Crystallographica Section E (2013) 69, 12 o1743-o1744
a=8.3860(6)Å b=11.8610(9)Å c=12.1102(9)Å
α=110.481(7)° β=108.093(7)° γ=92.329(6)°
1-Piperonylpiperazinium picrate
C12H17N2O2,C6H2N3O7
Acta Crystallographica Section E (2014) 70, 2 o208-o209
a=12.0864(2)Å b=6.96981(11)Å c=23.4898(4)Å
α=90° β=96.5141(17)° γ=90°
3-(4-Fluorophenyl)-1<i>H</i>-pyrazole--5-(4-fluorophenyl)-1<i>H</i>-pyrazole (1/1)
C9H7FN2
Acta Crystallographica Section E (2014) 70, 9 o949-o950
a=10.3961(5)Å b=10.8565(6)Å c=16.1431(7)Å
α=84.704(4)° β=76.223(4)° γ=68.249(5)°
<i>N</i>-(3-Benzoyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)benzamide
C22H19NO2S
Acta Crystallographica Section E (2014) 70, 9 o951-o952
a=13.5223(4)Å b=6.23222(15)Å c=22.2941(6)Å
α=90° β=106.150(3)° γ=90°
2,5-dimethylphenyl quinoline-2-carboxylate
C18H15NO2
Acta Crystallographica Section E (2014) 70, 2 o147
a=8.2261(3)Å b=11.6007(5)Å c=14.5738(5)Å
α=90° β=90° γ=90°
Flupentixol tartrate
C23H26F3N2OS,C4H5O6
Acta Crystallographica Section E (2014) 70, 2 o206-o207
a=9.9239(3)Å b=9.1968(3)Å c=30.0099(8)Å
α=90° β=96.617(3)° γ=90°
5-Aminopyrazol-2-ium hydrogen succinate
C3H6N3,C4H5O4
Acta Crystallographica Section E (2014) 70, 2 o221-o222
a=18.525(3)Å b=6.7872(9)Å c=14.564(3)Å
α=90° β=108.900(18)° γ=90°
Enrofloxacinium oxalate
2(C19H23FN3O3),C2O42
Acta Crystallographica Section E (2014) 70, 2 o200-o201
a=9.8552(5)Å b=13.3056(8)Å c=15.6124(8)Å
α=68.987(5)° β=84.740(4)° γ=73.093(5)°
[2-(1-Hydroxycyclohexyl)-2-(4-hydroxyphenyl)ethyl]dimethylammonium chloranilate ethyl acetate
C16H26NO2,C6HCl2O4,C4H8O2
Acta Crystallographica Section E (2013) 69, 10 o1556-o1557
a=11.1738(2)Å b=9.39846(16)Å c=13.6046(2)Å
α=90.00° β=105.109(2)° γ=90.00°
3-(1<i>H</i>-Imidazol-1-yl)propanaminium picrate
C6H2N3O7,C6H12N3
Acta Crystallographica Section E (2013) 69, 10 o1572-o1573
a=11.98275(18)Å b=38.5234(6)Å c=16.4239(2)Å
α=90° β=94.1970(14)° γ=90°
Diphenylmethyl benzoate
C20H16O2
Acta Crystallographica Section E (2013) 69, 1 o81
a=5.75357(19)Å b=16.0368(5)Å c=8.3114(3)Å
α=90.0° β=95.340(3)° γ=90.0°
4-<i>tert</i>-butyl-<i>N</i>-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)- 2-(pyrimidin-2-yl)pyrimidin-4-yl]benzene-1-sulfonamide monohydrate
C27H29N5O6S,H2O
Acta Crystallographica Section E (2013) 69, 1 o12-o13
a=12.3393(4)Å b=15.1238(6)Å c=14.6988(4)Å
α=90.00° β=95.037(3)° γ=90.00°
{2-[(4-Nitrobenzylidene)amino]-4,5,6,7-tetrahydro-1-benzothiophen-3-yl}(phenyl)methanone
C22H18N2O3S
Acta Crystallographica Section E (2014) 70, 6 o738-o739
a=4.61595(13)Å b=17.6844(4)Å c=11.7068(3)Å
α=90° β=91.285(3)° γ=90°
4-acetylpiperazinium picrate
C6H13N2O,C6H2N3O7
Acta Crystallographica Section E (2014) 70, 6 o717-o718
a=6.6843(7)Å b=11.5971(12)Å c=20.131(2)Å
α=90° β=90.000(4)° γ=90°
[2-(Biphenyl-4-yl)-1,3-thiazol-4-yl]methanol
C16H13NOS
Acta Crystallographica Section E (2012) 68, 10 o2950
a=6.05424(18)Å b=29.3096(9)Å c=7.2064(2)Å
α=90.00° β=92.668(3)° γ=90.00°
Orphenadrinium dihydrogen citrate
C18H24NO,C6H7O7
Acta Crystallographica Section E (2013) 69, 2 o248
a=9.9515(8)Å b=10.7382(9)Å c=12.6250(10)Å
α=98.863(7)° β=104.391(7)° γ=111.498(8)°
Ethyl 6-(6-methoxynaphthalen-2-yl)-4-(naphthalen-2-yl)-2-oxocyclohex-3-ene-1-carboxylate
C30H26O4
Acta Crystallographica Section E (2013) 69, 3 o352
a=18.4688(10)Å b=11.2940(6)Å c=10.9676(5)Å
α=90.00° β=96.082(5)° γ=90.00°
4-Amino-<i>N</i>-<i>tert</i>-butyl-5-oxo-3-(propan-2-yl)-1<i>H</i>-1,2,4-triazole-1-carboxamide
C10H19N5O2
Acta Crystallographica Section E (2013) 69, 4 o603
a=11.0298(2)Å b=12.2135(4)Å c=14.8542(4)Å
α=92.244(2)° β=95.7020(19)° γ=93.379(2)°
4-Amino-3-(4-hydroxybenzyl)-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C9H10N4OS
Acta Crystallographica Section E (2014) 70, 1 o48-o49
a=4.2117(5)Å b=6.1891(7)Å c=10.0641(11)Å
α=100.590(9)° β=94.916(9)° γ=104.589(10)°
4-[(<i>E</i>)-(4-Chlorobenzylidene)amino]-3-methyl-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C10H9ClN4S
Acta Crystallographica Section E (2014) 70, 1 o57-o58
a=7.0718(8)Å b=7.2901(8)Å c=11.8434(7)Å
α=92.778(7)° β=94.986(7)° γ=109.752(10)°
(4-Methylpiperazin-1-yl)-(2,3,4-trimethoxybenzylidene)amine
C15H23N3O3
Acta Crystallographica Section E (2014) 70, 4 o500
a=7.84207(14)Å b=14.2305(3)Å c=27.6218(5)Å
α=90° β=90° γ=90°
6-Chloro-2-chloromethyl-4-phenylquinazoline 3-oxide
C15H10Cl2N2O
Acta Crystallographica Section E (2014) 70, 4 o440-o441
a=8.2030(3)Å b=14.3203(5)Å c=11.8477(4)Å
α=90° β=105.016(4)° γ=90°
{2-[(1<i>H</i>-Indol-3-ylmethylidene)amino]-4,5,6,7-tetrahydrobenzo[<i>b</i>]thiophen-3-yl}(phenyl)methanone
C24H20N2OS
Acta Crystallographica Section E (2014) 70, 4 o501-o502
a=8.66858(16)Å b=21.8200(4)Å c=10.41956(18)Å
α=90° β=108.1709(19)° γ=90°
{2-[(2-Hydroxy-benzylidene)-amino]-4,5,6,7-tetrahydro-benzo[b]thiophen-3-yl}- phenyl-methanone
C22H19NO2S
Acta Crystallographica Section E (2014) 70, 4 o476-o477
a=9.26395(15)Å b=14.2886(2)Å c=13.6476(2)Å
α=90° β=96.7581(15)° γ=90°
5-(4-fluoro-phenyl)-2H-pyrazol-1-ium trifluoro-acetate
C9H8FN2,C2F3O2
Acta Crystallographica Section E (2014) 70, 4 o429-o430
a=6.7828(2)Å b=16.8263(6)Å c=10.4004(4)Å
α=90° β=93.354(3)° γ=90°
[2-(Benzylideneamino)-4,5,6,7-tetrahydrobenzo[<i>b</i>]thiophen-3-yl](phenyl)methanone
C22H19NOS
Acta Crystallographica Section E (2014) 70, 5 o507-o508
a=8.78760(16)Å b=14.0091(3)Å c=14.4120(2)Å
α=90° β=94.8913(17)° γ=90°
{2-[(2-Bromo-5-methoxybenzylidene)amino]-4,5,6,7-tetrahydrobenzo[<i>b</i>]thiophen-3-yl}(phenyl)methanone
C23H20BrNO2S
Acta Crystallographica Section E (2014) 70, 5 o581-o582
a=8.84813(17)Å b=12.5563(2)Å c=18.4384(4)Å
α=90° β=102.363(2)° γ=90°
1-3-aminopropyl imidazolium 3,5- dinitrosalicylate
C6H12N3,C7H3N2O7
Acta Crystallographica Section E (2014) 70, 3 o318-o319
a=7.0109(4)Å b=10.6617(8)Å c=10.7454(7)Å
α=93.075(6)° β=95.863(5)° γ=104.944(6)°
1-Piperonylpiperazinium p-chlorobenzoate
C12H17N2O2,C7H4ClO2
Acta Crystallographica Section E (2014) 70, 3 o283-o284
a=16.9967(6)Å b=8.5990(3)Å c=12.4150(5)Å
α=90° β=90.923(3)° γ=90°
1-(3,4-Dimethoxyphenyl)-3-phenylprop-2-en-1-one
C17H16O3
Acta Crystallographica Section E (2014) 70, 3 o368
a=7.3269(7)Å b=9.8923(11)Å c=10.7668(11)Å
α=102.408(9)° β=109.255(9)° γ=98.951(9)°
Rupatidine
C26H26ClN3
Acta Crystallographica Section E (2013) 69, 6 o980
a=10.2655(3)Å b=11.3341(4)Å c=18.8111(6)Å
α=90° β=90.874(3)° γ=90°
Methyl 2-{2-[(2-methylphenoxy)methyl]phenyl}-2-oxoacetate
C17H16O4
Acta Crystallographica Section E (2013) 69, 5 o671
a=31.6697(11)Å b=7.5883(2)Å c=12.5915(6)Å
α=90° β=108.514(4)° γ=90°
Methyl 2-[4-(trifluoromethyl)phenylsulfanyl]benzoate
C15H11F3O2S
Acta Crystallographica Section E (2013) 69, 11 o1670
a=11.0675(5)Å b=8.0429(3)Å c=15.6614(7)Å
α=90° β=96.654(5)° γ=90°
4-Methyl-<i>N</i>-(4-nitrobenzylidene)piperazin-1-amine
C12H16N4O2
Acta Crystallographica Section E (2013) 69, 11 o1687-o1688
a=27.9353(14)Å b=5.9247(3)Å c=18.7763(7)Å
α=90° β=126.527(3)° γ=90°
4-(3-Fluoro-4-methylanilino)-2-methylidene-4-oxobutanoic acid
C12H12FNO3
Acta Crystallographica Section E (2013) 69, 12 o1752
a=6.3368(3)Å b=8.2642(4)Å c=21.0277(11)Å
α=84.057(4)° β=89.798(4)° γ=86.062(4)°
4-Chloro-3-methylphenyl quinoline-2-carboxylate
C17H12ClNO2
Acta Crystallographica Section E (2013) 69, 12 o1842-o1843
a=7.75379(16)Å b=11.9658(3)Å c=14.9005(3)Å
α=90° β=90° γ=90°
4-Chlorophenyl quinoline-2-carboxylate
C16H10ClNO2
Acta Crystallographica Section E (2013) 69, 12 o1841
a=6.38693(18)Å b=16.8893(5)Å c=12.2649(4)Å
α=90° β=103.527(3)° γ=90°
N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)- 2-phenylacetamide
C19H19N3O2
Acta Crystallographica Section E (2013) 69, 12 o1726-o1727
a=10.1258(7)Å b=10.4671(8)Å c=17.8888(12)Å
α=100.833(6)° β=92.527(5)° γ=116.812(7)°
1-Piperonylpiperazinium 4-nitrobenzoate monohydrate
C12H17N2O2,C7H4NO4,H2O
Acta Crystallographica Section E (2014) 70, 3 o270-o271
a=6.0745(5)Å b=12.0617(11)Å c=13.4817(10)Å
α=92.561(7)° β=98.753(7)° γ=93.326(7)°
<i>N</i>-[3-(2-Chlorobenzoyl)-5-ethylthiophen-2-yl]-2-[(<i>E</i>)-(2-hydroxybenzylidene)amino]acetamide
C22H19ClN2O3S
Acta Crystallographica Section E (2014) 70, 9 o1011-o1012
a=9.7888(2)Å b=16.9476(3)Å c=12.2863(3)Å
α=90° β=90.6654(19)° γ=90°
3-[4-(Pyrimidin-2-yl)piperazin-1-ium-1-yl]butanoate
C12H18N4O2
Acta Crystallographica Section E (2014) 70, 9 o1063-o1064
a=13.5157(6)Å b=7.8454(3)Å c=12.2147(5)Å
α=90° β=106.884(5)° γ=90°
4-(Pyrimidin-2-yl)piperazin-1-ium chloride
C8H13N4,Cl
Acta Crystallographica Section E (2014) 70, 10 203-206
a=6.84764(17)Å b=7.27667(18)Å c=19.1751(5)Å
α=90° β=90° γ=90°
4-(Pyrimidin-2-yl)piperazin-1-ium nitrate
C8H13N4,NO3
Acta Crystallographica Section E (2014) 70, 10 203-206
a=10.5272(6)Å b=7.2230(3)Å c=14.1575(7)Å
α=90° β=107.341(6)° γ=90°
C29H29BrN2O7
C29H29BrN2O7
The Journal of organic chemistry (2018) 83, 21 13536-13542
a=14.6471(3)Å b=9.8270(2)Å c=19.3981(3)Å
α=90° β=104.564(2)° γ=90°
C27H25BrN2O6
C27H25BrN2O6
The Journal of organic chemistry (2018) 83, 21 13536-13542
a=6.1480(3)Å b=9.3553(7)Å c=21.4639(14)Å
α=97.508(6)° β=91.047(5)° γ=93.474(5)°
[(bpb)Ru(NO)(OEt)]
C20H17N5O4Ru
Inorganic Chemistry (2010) 49, 1487-1495
a=15.6611(17)Å b=13.0504(15)Å c=9.1589(10)Å
α=90.00° β=90.00° γ=90.00°
(NEt4)1.5(Na)0.5[(hybeb)Ru(NO)(OEt)].EtOH
C72H105N9NaO14Ru2
Inorganic Chemistry (2010) 49, 1487-1495
a=11.827(2)Å b=18.817(4)Å c=33.222(7)Å
α=90.00° β=96.74(3)° γ=90.00°
C14H28CuIN4S2
C14H28CuIN4S2
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1324-1339
a=7.4901(4)Å b=10.3906(4)Å c=14.1896(8)Å
α=102.429(4)° β=100.467(5)° γ=100.840(4)°
(PPh4)[(hypyb)Ru(NO)(OEt)].MeCN
C47H40N5O5PRu
Inorganic Chemistry (2010) 49, 1487-1495
a=9.9537(14)Å b=12.5967(17)Å c=17.043(2)Å
α=86.677(2)° β=73.852(2)° γ=86.616(2)°
C40H36Cu2N10,B2C64H24F48
C40H36Cu2N10,B2C64H24F48
Organometallics (2015) 34, 12 3047
a=25.813(3)Å b=25.813(3)Å c=36.552(4)Å
α=90.00° β=90.00° γ=90.00°
C60H58Cu4N16,2(C36H2B2F30N),2(CH2Cl2)
C60H58Cu4N16,2(C36H2B2F30N),2(CH2Cl2)
Organometallics (2015) 34, 12 3047
a=12.4419(5)Å b=15.8174(6)Å c=18.9305(7)Å
α=79.3320(10)° β=71.6490(10)° γ=80.7770(10)°